4.7 Article

The spectrum of nonmotor symptoms in early Parkinson disease

Journal

NEUROLOGY
Volume 80, Issue 3, Pages 276-281

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31827deb74

Keywords

-

Funding

  1. UK NIHR Biomedical Research Centre for Ageing and Age-related Disease
  2. NIHR Biomedical Research Centre funding University of Cambridge
  3. Addenbrooke's Hospital
  4. Newcastle University Lockhart Parkinson's Disease Fund
  5. Teva-Lundbeck
  6. GSK
  7. UCB Pharma
  8. Michael J. Fox Foundation
  9. UCB
  10. Abbott
  11. NIHR
  12. MRC
  13. Parkinson's UK
  14. EU
  15. GE Healthcare
  16. Cure-PD
  17. Rosetrees Trust
  18. Wellcome Trust
  19. GlaxoSmithKline Ltd
  20. Medical Research Council [MC_U120036861] Funding Source: researchfish
  21. Parkinson&quot
  22. s UK [J-0802] Funding Source: researchfish
  23. MRC [MC_U120036861] Funding Source: UKRI

Ask authors/readers for more resources

Objective: Nonmotor symptoms (NMS) are common in patients with established Parkinson disease (PD) but their frequency in early PD has not been extensively studied. Our aim was to determine the frequency of NMS in a cohort of patients with newly diagnosed PD. Methods: A total of 159 patients with early PD and 99 healthy controls participated in this study. NMS were screened for using the Nonmotor Symptom Questionnaire. Other assessments included measures of motor disability (Movement Disorders Society-revised Unified Parkinson's Disease Rating Scale [MDS-UPDRS]), disease severity (Hoehn & Yahr staging), depression (Geriatric Depression Scale), and global cognitive function (Mini-Mental State Examination and Montreal Cognitive Assessment). Results: The PD group reported a significantly greater number of NMS compared with controls (8.4 [4.3] vs 2.8 [2.6]). In the PD group, the most commonly experienced NMS were excessive saliva, forgetfulness, urinary urgency, hyposmia, and constipation. Patients with higher MDS-UPDRS III scores and those with the postural instability gait subtype experienced a greater number of NMS. Conclusion: NMS are common in early PD and reflect the multisystem nature of the disorder. Even in the earliest stages of PD, NMS may be detrimental to patients' functional status and sense of wellbeing. Neurology (R) 2013;80:276-281

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available